In this review, data about the heart rate variability (HRV) assessment in patients with chronic HF and the prognostic value of spectral and time analysis indicators are presented. The effect of the main drugs used for the treatment of HF on the HRV is described.
Key words: chronic heart failure, heart rate variability, prognosis.
Currently, the world incidence of chronic HF is 1-3% in the population under 70 years old, and 10% among those above 70 years old. About 1 million new HF cases are diagnosed annually (1). Studies of the incidence of such disease in the different countries indicate: 6.5 million diseased people in Europe, 5 millions in the United States, and 2.4 millions in Japan (2). In Russia, no less than 3-3.5 mill
主办单位:杭州德灵电子商务有限公司 杭州汉皇网络科技有限公司浙江省护理学会重症监护专业委员会网站协办单位:浙江省人民医院设备科 ;浙ICP备10209442号-3 
联系电话:0571-85065806 传真:0571-85065896 地址:杭州下城区高新技术产业基地电子商务园区费家塘路588号4号楼402-403室
Copyrigh ©2001-2009版权所有_杭州德灵电子商务有限公司 杭州汉皇网络科技有限公司 本网站法律顾问:汪卓君律师(浙江杭天信律师事务所)
execute:39.063